Janus Henderson Group plc 13D and 13G filings for Inovio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-08 11:45 am Purchase | 2025-11-28 | 13G | INOVIO PHARMACEUTICALS INC INO | JANUS HENDERSON GROUP PLC JHG | 6,666,295 9.990% | 3,400,035 (+104.10%) | Filing |
| 2025-11-14 10:34 am Purchase | 2025-09-30 | 13G | INOVIO PHARMACEUTICALS INC INO | JANUS HENDERSON GROUP PLC JHG | 3,266,260 6.200% | 3,266,260 (New Position) | Filing |